Burkholderia pseudomallei: Challenges for the clinical microbiology laboratory - a response from the front line.
The minireview by Hemajarata et al. (1) is timely since the global incidence of melioidosis has probably been grossly underestimated (2). However, the review reflects a very U.S. “select agent”-orientated perspective. In some parts of the world, laboratories isolate Burkholderia pseudomallei on an a...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
American Society for Microbiology
2017
|
| Summary: | The minireview by Hemajarata et al. (1) is timely since the global incidence of melioidosis has probably been grossly underestimated (2). However, the review reflects a very U.S. “select agent”-orientated perspective. In some parts of the world, laboratories isolate Burkholderia pseudomallei on an almost daily basis; our own laboratories diagnose more than 600 cases of culture-positive melioidosis each year, giving us a different perspective. |
|---|